1] Cabral BMI, Edding SN, Portocarrero JP, et al. Rhabdomyolysis [J]. Dis Mon, 2020, 66(8): 101015.
[2] Gupta A, Thorson P, Penmatsa KR, et al. Rhabdomyolysis: Revisited [J]. Ulster Med J, 2021, 90(2): 61-69.
[3] Long B, Targonsky E, Koyfman A. Just the Facts: Diagnosis and management of rhabdomyolysis [J]. Cjem, 2020, 22(6): 745-748.
[4] Stahl K, Rastelli E, Schoser B. A systematic review on the definition of rhabdomyolysis [J]. J Neurol, 2020, 267(4): 877-882.
[5] Candela N, Silva S, Georges B, et al. Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients [J]. Ann Intensive Care, 2020, 10(1): 27.
[6] Mlynarska E, Krzeminska J, Wronka M, et al. Rhabdomyolysis-Induced AKI (RIAKI) Including the Role of COVID-19 [J]. Int J Mol Sci, 2022, 23(15).
[7] Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review [J]. Crit Care, 2014, 18(3): 224.
[8] Zhang L, Kang Y, Fu P, et al. Myoglobin clearance by continuous venous-venous haemofiltration in rhabdomyolysis with acute kidney injury: a case series [J]. Injury, 2012, 43(5): 619-623.
[9] Bajema IM, Rotmans JI. Histological manifestations of rhabdomyolysis in the kidney [J]. Nephrol Dial Transplant, 2018, 33(12): 2113-2114.
[10] Somagutta MR, Pagad S, Sridharan S, et al. Role of Bicarbonates and Mannitol in Rhabdomyolysis: A Comprehensive Review [J]. Cureus, 2020, 12(8): e9742.
[11] Yang J, Zhou J, Wang X, et al. Risk factors for severe acute kidney injury among patients with rhabdomyolysis [J]. BMC Nephrol, 2020, 21(1): 498.
[12] Tan Z, Guo F, Huang Z, et al. Pharmacological and genetic inhibition of fatty acid‐binding protein 4 alleviated cisplatin‐induced acute kidney injury [J]. Journal of Cellular and Molecular Medicine, 2019, 23(9): 6260-6270.
[13] Grivei A, Giuliani KTK, Wang X, et al. Oxidative stress and inflammasome activation in human rhabdomyolysis-induced acute kidney injury [J]. Free Radical Biology and Medicine, 2020, 160: 690-695.
[14] Kodadek L, Carmichael Ii SP, Seshadri A, et al. Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document [J]. Trauma Surg Acute Care Open, 2022, 7(1): e000836.
[15] Long B, Koyfman A, Gottlieb M. An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis [J]. Am J Emerg Med, 2019, 37(3): 518-523.
[16] Secombe P, Milne C. Hyponatraemia-induced rhabdomyolysis complicated by anuric acute kidney injury: a renal replacement conundrum [J]. BMJ Case Rep, 2016, 2016.
[17] Heung M, Yessayan L. Renal Replacement Therapy in Acute Kidney Injury: Controversies and Consensus [J]. Crit Care Clin, 2017, 33(2): 365-378.
[18] Tandukar S, Palevsky PM. Continuous Renal Replacement Therapy: Who, When, Why, and How [J]. Chest, 2019, 155(3): 626-638.
[19] 陈德政, 张凌, 李明鹏, 等. 连续性肾脏替代治疗在蜂蜇伤致横纹肌溶解合并急性肾损伤中的应用 [J]. 华西医学, 2018, 33(07): 848-851.
[20] Bellomo R, Daskalakis M, Parkin G, et al. Myoglobin clearance during acute continuous hemodiafiltration [J]. Intensive Care Med, 1991, 17(8): 509.
[21] Ricci Z, Romagnoli S, Reis T, et al. Hemoperfusion in the intensive care unit [J]. Intensive Care Med, 2022, 48(10): 1397-1408.
[22] Boparai S, Lakra R, Dhaliwal L, et al. Therapeutic Plasma Exchange in Severe Rhabdomyolysis: A Case-Control Study [J]. Cureus, 2023, 15(5): e39748.
[23] Ronco C, Bellomo R. Hemoperfusion: technical aspects and state of the art [J]. Crit Care, 2022, 26(1): 135.
[24] Li L, Bo W, Chen H, et al. Hemoperfusion plus continuous veno-venous hemofiltration in the treatment of patients with multiple organ failure after wasp stings [J]. The International Journal of Artificial Organs, 2019, 43(3): 143-149.
[25] Li Z, Wang G, Zhen G, et al. Effects of hemodialysis combined with hemoperfusion on severe acute pancreatitis [J]. Turk J Gastroenterol, 2018, 29(2): 198-202.
[26] McMahon GM, Zeng X, Waikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis [J]. JAMA Intern Med, 2013, 173(19): 1821-1828.
[27] Simpson JP, Taylor A, Sudhan N, et al. Rhabdomyolysis and acute kidney injury: creatine kinase as a prognostic marker and validation of the McMahon Score in a 10-year cohort: A retrospective observational evaluation [J]. Eur J Anaesthesiol, 2016, 33(12): 906-912.
[28] Vangstad M, Bjornaas MA, Jacobsen D. Rhabdomyolysis: a 10-year retrospective study of patients treated in a medical department [J]. European Journal of Emergency Medicine, 2019, 26(3): 199-204.
[29] Li X, Bai M, Yu Y, et al. Earlier continuous renal replacement therapy is associated with reduced mortality in rhabdomyolysis patients [J]. Renal Failure, 2022, 44(1): 1753-1763.
[30] Napp LC, Ziegeler S, Kindgen-Milles D. Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support [J]. Blood Purif, 2019, 48(3): 203-214.
[31] Moresco E, Rugg C, Strohle M, et al. Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb((R)))-A case report [J]. Clin Case Rep, 2022, 10(1): e05272.
[32] Rauch S, Borgato A, Gruber E, et al. Case Report: Prevention of Rhabdomyolysis-Associated Acute Kidney Injury by Extracorporeal Blood Purification With Cytosorb((R)) [J]. Front Pediatr, 2021, 9: 801807.
[33] Hui WF, Hon KL, Lun KS, et al. Successful Treatment of Rhabdomyolysis-Associated Acute Kidney Injury with Haemoadsorption and Continuous Renal Replacement Therapy [J]. Case Rep Pediatr, 2021, 2021: 2148024.
[34] Scharf C, Liebchen U, Paal M, et al. Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis [J]. Critical Care, 2021, 25(1).
[35] Gautam SC, Lim J, Jaar BG. Complications Associated with Continuous RRT [J]. Kidney360, 2022, 3(11): 1980-1990.
[36] Akhoundi A, Singh B, Vela M, et al. Incidence of Adverse Events during Continuous Renal Replacement Therapy [J]. Blood Purif, 2015, 39(4): 333-339.
[37] He Z, Lu H, Jian X, et al. The Efficacy of Resin Hemoperfusion Cartridge on Inflammatory Responses during Adult Cardiopulmonary Bypass [J]. Blood Purification, 2021, 51(1): 31-37.
